Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic

Journal of Medical Virology

Volumn 78, Issue SUPPL. 1, 2006, Pages

  Barin, Francis ^a,d   Plantier, Jean Christophe ^b   Brand, Denys ^a   Brunet, Sylvie ^a   Moreau, Alain ^a   Liandier, Benoit ^a   Thierry, Damien ^a   Cazein, Françoise ^c   Lot, Florence ^c   Semaille, Caroline ^c   Desenclos, Jean Claude ^c  

^a UNIVERSITÉ DE TOURS   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

^c INSTITUT DE VEILLE SANITAIRE   (France)

^d CHU BRETONNEAU   (France)

Author keywords

Dried blood spots; Epidemiological surveillance; Human immunodeficiency virus; Subtypes

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ANTIGEN BINDING; BLOOD STAIN; DIAGNOSTIC PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FRANCE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; NONHUMAN; PROTEIN DOMAIN; REVIEW; SEROTYPING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA, CENTRAL; BLOOD SPECIMEN COLLECTION; FEASIBILITY STUDIES; FRANCE; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV-1; HIV-2; HUMANS; IMMUNOASSAY; IMMUNODOMINANT EPITOPES; PEPTIDE FRAGMENTS; POPULATION SURVEILLANCE; PREVALENCE; SEROTYPING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 33745618175     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20600     Document Type: Review

References (34)

1. Baillou A, Janvier B, Leonard G, Denis F, Goudeau A, Barin F. 1991. Fine serotyping of human immunodeficiency virus serotype 1 (HIV1) and HIV2 infections by using synthetic oligopeptides representing an immunodominant domain of HIV1 and HIV2/simian immunodeficiency virus. J Clin Microbiol 29:1387-1391.
2. Baillou A, Brand D, Denis F, M'Boup S, Chout R, Goudeau A, Barin F. 1993. High antigenic cross-reactivity of the V3 consensus sequences of HIV1 gp120. AIDS Res Hum Retrovir 9:1203-1209.
3. Barin F, Mulanga MC. 1994. Diagnostic tools. In: Essex M, M'Boup S, Kanki P, Kalengayi MR, editors. AIDS in Africa. New York: Raven Press. pp. 109-131.
4. Barin F, Lahbabi Y, Buzelay L, Lejeune B, Baillou-Beaufils A, Denis F, Mathiot C, M'Boup S, Vithayasai V, Dietrich U, Goudeau A. 1996. Diversity of antibody binding to V3 peptides representing consensus sequences of HIV1 genotypes A to E: An approach for HIV1 serological subtyping. AIDS Res Hum Retrovir 12:1279-1289.
5. Barin F, Courouce AM, Pillonel J, Buzelay L, the Retrovirus Study Group of the French Society of Blood Transfusion. 1997. Increasing diversity of HIV-1M serotypes in French blood donors over a 10-year period (1985-1995). AIDS 11:1503-1508.
6. Barin F, Meyer L, Lancar R, Deveau C, Gharib M, Laporte A, Desenclos JC, Costagliola D. 2005. An immunoassay for the identification of recent HIV-1 infections: Development, validation and use on dried blood spots. J Clin Microbiol 43:4444-4447.
7. Beck IA, Drennan KD, Melvin AJ, Mohan KM, Herz AM, Alarcon J, Piscoya J, Velasquez C, Frenkel LM. 2001. Simple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the field. J Clin Microbiol 39:29-33.
8. Biggar RJ, Miley W, Miotti P, Taha TE, Butcher A, Spadaro J, Waters D. 1997. Blood collection on filter paper: A practical approach to sample collection for studies of perinatal HIV transmission. J AIDS 14:368-373.
9. Brambilla D, Jennings C, Aldrovandi G, Bremer J, Comeau A, Cassol SA, Dickover R, Jackson JB, Pitt J, Sullivan JC, Butcher A, Grosso L, Reichelderfer P, Fiscus SA. 2003. Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: Measurement, precision, and RNA stability. J Clin Microbiol 41:1888-1893.
10. Brand D, Beby-Defaux A, Mace M, Brunet S, Moreau A, Godet C, Jais X, Cazein F, Semaille C, Barin F. 2004. First identification of HIV-1 groups M and O dual infections in Europe. AIDS 18:2425-2430.
11. Cassol SWB, Babu PG, Salminen MO, Zheng X, Htoon MT, Delaney A, O'Shaugnessy M, Ou CY. 1996. Detection of HIV type 1 env subtypes A, B, C, and E in Asia using dried blood spots: A new surveillance tool for molecular epidemiology. AIDS Res Hum Retrovir 12:1435-1441.
12. Cheingsong-Popov R, Osmanov S, Pau CP, Schochetman G, Barin F, Holmes H, Francis G, Ruppach H, Dietrich U, Lister S, Weber J, the UNAIDS Network for HIV-1 Isolation and Characterization. 1998. Serotyping of HIV-1 infections: Definition, classification, relationship to viral genetic subtypes and assay evaluation. AIDS Res Hum Retrovir 14:311-318.
13. Couturier E, Damond F, Roques P, Fleury H, Barin F, Brunet JB, Brun-Vezinet F, Simon F, the AC11 Laboratory Network. 2000. HIV-1 diversity in France, 1996-1998. AIDS 14:289-296.
14. Delwart E, Shpaer E, Louwagie J, McCutchan FE, Grez M, Rubsamen-Waigmann H, Mullins JI. 1993. Genetic relationships determined by a DNA heteroduplex mobility assay: Analysis of HIV-1 env genes. Science 262:1257-1261.
15. Hoelscher M, Hanker S, Barin F, Cheingsong-Popov R, Dietrich U, Jordan-Harder B, Olaleye D, Nagele E, Markuzzi A, Mwakagile DL, Minja F, Weber J, Gurtler L, von Sonnenburg F. 1998. HIV-1 V3 serotyping in Tanzanian samples; probable reasons for mismatching with genetic subtyping. AIDS Res Hum Retrovir 14:139-149.
16. Hoelscher M, Dowling WE, Sanders-Buell E, Carr JK, Harris ME, Thomschke A, Robb ML, Birx DL, McCutchan FE. 2002. Detection of HIV-1 subtypes, recombinants, and dual infections in east Africa by a multi-region hybridization assay. AIDS 18:2055-2064.
17. Lange JM, Teeuwsen VJ, Boucher CA, Vahlne A, Barin F, Tjong S, Hung A, Dekkeer J, Parkhede U, de Wolf F, Goudsmit J. 1993. Antigenic variation of the dominant gp41 epitope in Africa. AIDS 7:461-466.
18. Lot F, Semaille C, Cazein F, Barin F, Pinget R, Pillonel J, Desenclos JC. 2005. Preliminary results from the new HIV surveillance system in France. Eurosurveillance 9:34-36.
19. Mauclere P, Damond F, Apetrei C, Loussert-Ajaka I, Souquiere S, Buzelay L, Dalbon P, Jolivet M, Mony Lobe M, Brun-Vezinet F, Simon F, Barin F. 1997. Synthetic peptide ELISAs for detection of and discrimination between group M and group O HIV-1 infection. AIDS Res Hum Retrovir 13:987-993.
20. Nkengasong JN, Willems B, Janssens W, Cheingsong-Popov R, Heyndrickx L, Barin F, Ondoa P, Fransen K, Goudsmit J, Van der Groen G. 1998. Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing. AIDS 12:1405-1412.
21. O'Shea SMJ, Corbett K, Chrystie I, Newell ML, Banatvala JE. 1999. Use of dried whole blood spots for quantification of HIV-1 RNA. AIDS 13:630-631.
22. Peeters M, Gueye A, M'Boup S, Bibollet-Ruche F, Ekaza E, Mulanga C, Ouedrago R, Gandji R, Mpele P, Dibanga G, Koumaré B, Saidou M, Esu-Williams E, Lombart JP, Badombena W, Luo N, van den Haesevelde M, Delaporte E. 1997. Geographical distribution of HIV-1 group O viruses in Africa. AIDS 11:493-498.
23. Peeters M, Liegeois F, Torimiro N, Bourgeois A, Mpoudi E, Vergne L, Saman E, Delaporte E, Saragosti S. 1999. Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient. J Virol 73:7368-7375.
24. Perrin L, Kaiser L, Yerly S. 2003. Travel and the spread of HIV-1 genetic variants. Lancet Infect Dis 3:22-27.
25. Plantier JC, Damond F, Lasky M, Sankalé JL, Apetrei JL, Peeters M, Buzelay L, M'Boup L, Kanki P, Delaporte E, Simon F, Barin F. 1999. V3 serotyping of HIV-1 infection: Correlation with genotyping and limitations. J AIDS 20:432-441.
26. Plantier JC, Damond F, Souquieres S, Brun-Vezinet F, Simon F, Barin F. 2001. V3 serological subtyping of HIV type 2 infection is not relevant. J Clin Microbiol 39:3803-3807.
27. Plantier JC, Vergne L, Damond F, M'Boup S, Mpoudi-Ngole E, Buzelay L, Farfara I, Brand D, Peeters M, Brun-Vezinet F, Delaporte E, Barin F. 2002. Development and evaluation of a DNA enzyme immunoassay method for env genotyping of subtypes A through G of HIV-1 group M, with discrimination of the circulating recombinant forms CRF01_AE and CRF02_AG. J Clin Microbiol 40:1010-1022.
28. Plantier JC, Dachraoui R, Lemée V, Gueudin M, Borsa-Lebas F, Caron F, Simon F. 2005. HIV-1 resistance genotyping on dried serum spots. AIDS 19:391-397.
29. Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK, Gao F, Hahn BH, Kalish ML, Kuiken C, Learn GH, Leitner T, McCutchan F, Osmanov S, Peeters M, Pieniazek D, Salminen M, Sharp PM, Wolinsky S, Korber B. 2000. HIV-1 nomenclature proposal. Science 288:55-56.
30. Simon F, Mauclère P, Roques P, Loussert-Ajaka I, Müller-Trutwin M, Saragosti S, Georges-Courbot MC, Barré-Sinoussi F, Brun-Vézinet F. 1998. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 4:1032-1037.
31. Subbarao S, Limpakarnjanarat K, Mastro TD, Bhumisawasdi J, Warachit P, Jayavasu C, Young NL, Luo CC, Shaffer N, Kalish ML, Schochetman G. 1998. HIV type 1 in Thailand, 1994-1995: Persistence of two subtypes with low genetic diversity. AIDS Res Hum Retrovir 14:319-327.
32. Takehisa J, Zekeng L, Ido E, Yamaguchi-Kabata Y, Mboudjeka I, Harada Y, Miura T, Kaptu L, Hayami M. 1999. Human immunodeficiency virus type 1 intergroup (M/O) recombination in Cameroon. J Virol 73:6810-6820.
33. Van Harmelen J, Wood R, Lambrick M, Rybicki EP, Williamson AL, Williamson C. 1997. An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa. AIDS 11:81-87.
34. Yamaguchi J, Bodelle P, Vallari AS, Coffey R, McArthur CP, Schochetman G, Devare SG, Brennan CA. 2004. HIV infections in northwestern Cameroon: Identification of HIV type 1 group O and dual HIV type 1 group M and Group O infections. AIDS Res Hum Retrovir 20:944-957.